These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31354428)

  • 1. Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR.
    Silberbauer LR; Gryglewski G; Berroterán-Infante N; Rischka L; Vanicek T; Pichler V; Hienert M; Kautzky A; Philippe C; Godbersen GM; Vraka C; James GM; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Hahn A; Lanzenberger R
    Front Mol Neurosci; 2019; 12():172. PubMed ID: 31354428
    [No Abstract]   [Full Text] [Related]  

  • 2. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
    J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET measurement of "GABA shift" in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [
    Kim W; Park HS; Moon BS; Lee BC; Kim SE
    Nucl Med Biol; 2017 Feb; 45():30-34. PubMed ID: 27886620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging.
    Gryglewski G; Klöbl M; Berroterán-Infante N; Rischka L; Balber T; Vanicek T; Pichler V; Kautzky A; Klebermass EM; Reed MB; Vraka C; Hienert M; James GM; Silberbauer L; Godbersen GM; Unterholzner J; Michenthaler P; Hartenbach M; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hahn A; Hacker M; Kasper S; Lanzenberger R
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):711-719. PubMed ID: 31076187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [
    Kim JH; Son YD; Kim HK; Kim JH
    Neuropsychiatr Dis Treat; 2021; 17():3195-3203. PubMed ID: 34707358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI.
    Rischka L; Gryglewski G; Berroterán-Infante N; Rausch I; James GM; Klöbl M; Sigurdardottir H; Hartenbach M; Hahn A; Wadsak W; Mitterhauser M; Beyer T; Kasper S; Prayer D; Hacker M; Lanzenberger R
    Front Physiol; 2019; 10():1422. PubMed ID: 31824335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of scan-time shortening on the
    Matsunaga K; Tonomura M; Abe K; Shimosegawa E
    Ann Nucl Med; 2023 Apr; 37(4):227-237. PubMed ID: 36656501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET.
    Fischer K; Sossi V; von Ameln-Mayerhofer A; Reischl G; Pichler BJ
    Neuroimage; 2012 Feb; 59(3):2413-22. PubMed ID: 21945469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.
    Hinz R; Selvaraj S; Murthy NV; Bhagwagar Z; Taylor M; Cowen PJ; Grasby PM
    J Cereb Blood Flow Metab; 2008 Aug; 28(8):1478-90. PubMed ID: 18478022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
    Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates.
    Hwang DR; Hu E; Rumfelt S; Easwaramoorthy B; Castrillon J; Davis C; Allen JR; Chen H; Treanor J; Abi-Dargham A; Slifstein M
    Nucl Med Biol; 2014 Apr; 41(4):343-9. PubMed ID: 24607437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11C-flumazenil in awake and anesthetized animals.
    Sandiego CM; Jin X; Mulnix T; Fowles K; Labaree D; Ropchan J; Huang Y; Cosgrove K; Castner SA; Williams GV; Wells L; Rabiner EA; Carson RE
    J Nucl Med; 2013 Nov; 54(11):1962-8. PubMed ID: 24115528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
    Catafau AM; Pérez V; Penengo MM; Bullich S; Danús M; Puigdemont D; Pascual JC; Corripio I; Llop J; Perich J; Alvarez E
    J Nucl Med; 2005 Aug; 46(8):1301-9. PubMed ID: 16085586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.
    Talbot PS; Bradley S; Clarke CP; Babalola KO; Philipp AW; Brown G; McMahon AW; Matthews JC
    Neuropsychopharmacology; 2010 Feb; 35(3):741-51. PubMed ID: 19890256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-validation study between the HRRT and the PET component of the SIGNA PET/MRI system with focus on neuroimaging.
    Mannheim JG; Cheng JK; Vafai N; Shahinfard E; English C; McKenzie J; Zhang J; Barlow L; Sossi V
    EJNMMI Phys; 2021 Feb; 8(1):20. PubMed ID: 33635449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
    Wilson H; Giordano B; Turkheimer FE; Chaudhuri KR; Politis M
    Neuroimage Clin; 2018; 18():630-637. PubMed ID: 29845011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.